Givaudan (GIVN) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
13 Apr, 2026Business overview and strategy
Operates in Taste & Wellbeing and Fragrance & Beauty, focusing on creativity, innovation, and collaboration to meet evolving consumer needs.
Maintains a naturally hedged portfolio across geographies and product categories, with 51% of sales in mature markets and 49% in high-growth markets.
2030 strategy targets 4–6% like-for-like growth and over 12% free cash flow, emphasizing sustainable growth, customer reach, and portfolio expansion.
Growth drivers include extending customer reach, deepening geographical presence, and expanding into high-value adjacencies like beauty and pet food.
Focuses on innovation, digital transformation, and sustainability as core differentiators.
Financial performance
Achieved CHF 7,472 million in 2025 sales, with 5.1% like-for-like growth and 24.2% comparable EBITDA margin.
Net income for 2025 was CHF 1,071 million (14.3% of sales), with free cash flow at CHF 1,053 million (14.1% of sales).
Dividend per share increased for the 25th consecutive year, up 2.9% over 2025.
Maintains a balanced debt structure with a weighted average effective interest rate of 1.94% as of December 2025.
All regions contributed to growth, with high-growth markets showing 8.0% like-for-like sales increase.
Operational highlights
Taste & Wellbeing segment delivered CHF 3,642 million in sales, with a 21.7% comparable EBITDA margin.
Fragrance & Beauty segment achieved CHF 3,830 million in sales, with a 26.5% comparable EBITDA margin.
Invested CHF 551 million in R&D in 2025 (7.4% of sales), supporting over 5,000 active patents and 65 creation and research centers.
Over 300,000 customer briefs handled annually, with strong IP protection and high customer switching costs.
Recent acquisitions have strengthened capabilities in natural ingredients, biotechnology, and digital innovation.
Latest events from Givaudan
- 5.1% LFL sales growth, CHF 1,071m net income, and 25th consecutive dividend increase.GIVN
H2 202517 Apr 2026 - Q1 2026 sales rose 2.8% LFL, led by Fragrance & Beauty, despite currency and cost pressures.GIVN
Q1 2026 TU14 Apr 2026 - Strong 2025 growth, resilient margins, and ambitious sustainability targets drive future strategy.GIVN
Investor presentation16 Mar 2026 - Double-digit sales and profit growth, margin expansion, and strong cash flow mark the half year.GIVN
H1 20243 Feb 2026 - Sales up 6.3% LFL, EBITDA margin 25.2%, net income CHF 592m, free cash flow negative.GIVN
H1 20253 Feb 2026 - Double-digit sales and profit growth, led by high-growth markets and a record dividend increase.GIVN
H2 20249 Jan 2026 - Sales up 5.7% LFL, led by Fine Fragrance and high growth markets, exceeding growth targets.GIVN
Q3 202514 Oct 2025 - Nine-month sales rose 13.0% LFL, driven by strong growth in all segments and regions.GIVN
Q3 202413 Jun 2025 - Strong growth, innovation, and ESG leadership drive Givaudan’s robust financial performance.GIVN
Investor Presentation13 Jun 2025